The largest database of trusted experimental protocols

5 protocols using pecy5 anti cd4

1

Characterization of Colonic Foxp3+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The colonic tissues from Foxp3-GFP mice were prepared for processing single-cell suspensions of lymphocytes from colonic lamina propria, as described previously.18 (link) Cells were labeled with LIVE/DEAD fixable viability dyes (#2443413, Invitrogen, Waltham, MA) and PE-Cy5-anti-CD4 (#100410, BioLegend, San Diego, CA) at room temperature. Then, cells were analyzed using multi-color flow cytometry, a BD LSRII system (BD Biosciences) to determine the percentage of GFP (Foxp3 expression) and PE-Cy5.5 (CD4 expression) double positive cells within live cell population. Each sample contained lymphocytes from 2 to 3 mice with the same treatment.
+ Open protocol
+ Expand
2

Immune Cell Profiling in Tamoxifen-Treated Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
EDTA-blood was collected from the orbital sinus 2 weeks after last tamoxifen injection. Per mouse, 50µL blood were diluted in 50µL PBS and overlaid on 100µL lymphocyte separation medium (1077, PromoCell). After centrifugation, peripheral blood mononuclear cells were isolated, washed and stained for 15 min at 4 °C with the following antibodies: PECy5 anti-CD4 (1:1000, clone H129.19, Biolegend), PECy7 anti-CD8 (1:500, clone 53–6.7, Biolegend), BV510 anti-B220 (1:500, clone RA3-6B2, Biolegend) and PerCpCy5.5 anti-CD11b (1:100, clone M1/70, Biolegend). After staining, cells were washed, suspended in 200µL PBS containing 2% bovine serum albumin (#8076.3, Roth), and filtered through 40 µm cell strainers. Samples were measured on a FACSAria Sorp (BD). Number of lymphocytes were determined using forward and side scatter. Frequency of T-helper cells (CD4+,CD8), cytotoxic T-cells (CD8+, CD4), B cells (B220+, CD11b, CD8, CD4), and myeloid cells (CD11b+, B220, CD8, CD4) were determined as percentage of total lymphocytes.
+ Open protocol
+ Expand
3

Comprehensive Immune Cell Analysis in Murine Tumor Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
The immune phenotype of splenocytes and tumor infiltrating lymphocytes (TIL) were analyzed in all the three models by flow cytometry. TILs were isolated as previously described [12 (link)]. Splenocytes were processed for analysis according to our previously published methods [13 (link)]. For FOXP3 and CD4/CD8 evaluation, 1μg anti-mouse CD16/CD32 (BD Pharmingen) was used to block nonspecific binding for 30 minutes at room temperature then 0.4μg each of PE anti-CD3 (BD Pharmingen, clone #145-2C11), PE/Cy5 anti-CD4 (BioLegend, clone #GK1.5), and PE-Cy7 anti-CD8 (eBioscience, clone #53-6.7) were added. After overnight permeabilization of the cells, 1μg anti-FOXP3 Alexa488 (eBioscience, clone #FJK.16s) was added for 30 minutes. For myeloid derived suppressor cell (MDSC) evaluation, 0.4μg of GR-1 (BD Pharmingen, clone #RB6-8C5) and anti-mouse CD11b were added and incubated for 30 minutes at room temperature (eBioscience clone #M1/70). After the appropriate antibodies were applied to each single cell suspension of tumor or spleen for 30 min at room temperature, the stained cells were acquired with FACSCanto flow cytometer (BD Bioscience) and analyzed with FlowJo software (Tree Star Inc.). Results are reported as mean ± SEM of the total percentage of a cell population or ratio of cell quantities, as indicated.
+ Open protocol
+ Expand
4

Multiplex Flow Cytometry of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Per mouse, 50 µL EDTA blood was diluted in 50 µL PBS and overlaid on 100 µL lymphocyte separation medium (1077, PromoCell). After centrifugation, cells were isolated from the interphase, washed and stained for 15 min at 4 °C with the following antibodies: PECy5 anti-CD4 (1:1000, clone H129.19, BioLegend), PECy7 anti-CD8 (1:500, clone 53-6.7, BioLegend), BV510 anti-B220 (1:333, clone RA3-6B2, BioLegend), PerCpCy5.5 anti-CD11b (1:1000, clone M1/70, BioLegend), PE anti-Gr1 (1:1000, clone RB6-8C5, BioLegend), and FITC anti-F4/80 (1:1000, BM8, BioLegend). After staining, cells were washed, suspended in 250 µL PBS containing 2% bovine serum albumin (#8076.3, Roth), and filtered through 40 µm cell strainers. Samples were measured on a FACSAria Sorp (BD). Total cell numbers were determined using forward and side scatter. Frequency of helper T cells (CD4+, CD8−), cytotoxic T cells (CD8+, CD4−), B cells (B220+), macrophages (CD11b+, F4/80+) and neutrophils/monocytes (CD11b+, Gr1+) were determined as percentage of total lymphocytes.
+ Open protocol
+ Expand
5

Nanoparticle-mediated Cancer Immunotherapy Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
DOTAP (1,2-dioleoyl-3-trimethylammonium-propane) (890890) and cholesterol (700000) lipids were purchased from Avanti Polar Lipids, Inc., Alabaster, AL, USA. Nanoplasmid (NTC 9385R-MCS) containing the CRT gene was purchased from Aldevron (Lincoln, NE, USA). Chloroform (C2432) was purchased from Sigma-Aldrich, St. Louis, MO, USA. HEPES, sterile 1 M buffer (J848), DMEM (11965092), Fetal bovine serum, FBS (10082147), Penicillin-Streptomycin - PenStrep (15140122), PBS (10010023), Collagenase IV (17104019), were purchased from ThermoFisher/Gibco, Waltham, MA, USA. The following Fluorochrome-conjugated monoclonal antibodies (mAbs) for flow cytometry were purchased from BioLegend, San Diego, CA, USA and were listed: APC-Cy7 anti-CD45 (103115), PerCP anti-CD3 epsilon (100325), PE-Cy5 anti-CD4 (100410), PE-Cy7 anti-CD8a (100721), PE anti-Granzyme B (372208), BV510 anti-INFg (505841), BV510 anti-Ly-6G (127633), PE anti-Ly-6C (128007), BV650 anti-CD11b (101239), APC anti-CD206 (141707), BV421 anti-CD11c (117329). AF488 anti-iNOS (53-5920-82) was procured from eBiosciences/ThermoFisher, Waltham, MA, USA. Liberase (5401119001) was procured from Life Technologies, NY, USA. Transcription factor buffer set (562574) was purchased from BD Biosciences, San Jose, CA, USA. B16F10 was provided by Dr. Mary Jo Turk, Dartmouth. Aged C57BL/6 mice were obtained from NIA, Bethesda, MD, USA.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!